Clinical Trial Update: Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide alone or in combination with thalidomide, isotretinoin, and/or celecoxib in glioblastoma multiforme patients post-radiatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Glioblastoma Multiforme

Drugs mentioned

• Celecoxib (Celecoxib)
• ISOTRETINOIN (Isotretinoin)
• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain and Central Nervous System Tumors, Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2021-10-18